Neurosense Therapeutics Ltd. · NASDAQ:NRSN
Ben-Noon Alon bought 250,000 Neurosense Therapeutics Ltd. shares (Form 4)
Traded Jun 16, 2026 · Filed Jun 17, 2026
On Jun 16, 2026, Ben-Noon Alon (Chief Executive Officer) bought 250,000 Neurosense Therapeutics Ltd. shares at US$0.80 for US$200K, leaving 4,534,233 shares. Filed Jun 17, 2026 (Form 4).
- Bought
- 250,000 shares
- Price
- US$0.80
- Value
- US$200K
- Holding after
- 4,534,233 shares
- Trading plan
- No
- Role
- Chief Executive Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 16, 2026 | Ordinary Shares | Buy | 250,000 | US$0.80 | 4,534,233 | Direct |